Largest ever trial into postpartum haemorrhage completed, says pharmas Ferring and MSD

The largest ever trial conducted in postpartum haemorrhage (PPH) has been completed, pharmaceuticals Ferring and MSD have said. Each year, more than 14 million mothers are affected by PPH. It is the leading cause of maternal mortality, accounting for 480,000 deaths between 2003 and 2009. Even when women survive, PPH can result in the need for serious medical interventions, including surgical removal of the uterus (hysterectomy) as well as blood transfusions to address severe anaemia. The CHAMPION (Carbetocin Haemorrhage Prevention), undertaken by trial Ferring and MSD, is a global clinical trial conducted by the Human Reproduction Program (HRP) at the